Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Carlisle Companies
CSL
$14.3B
| $122M | 0.02% |
636,073
-5,607
| -0.9% | -$1.04M |
|
702
First Financial Bankshares
FFIN
$5.04B
| $121M | 0.02% |
2,465,855
+67,839
| +3% | +$3.33M |
|
703
SEI Investments
SEIC
$12.4B
| $120M | 0.02% |
1,943,076
+41,235
| +2% | +$2.57M |
|
|
AZPN
704
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $120M | 0.02% |
874,031
+20,347
| +2% | +$2.8M |
|
705
Gentex
GNTX
$4.97B
| $120M | 0.02% |
3,613,962
-120,145
| -3% | -$4.17M |
|
|
GAP
706
The Gap Inc
GAP
$7.23B
| $120M | 0.02% |
3,563,242
+106,557
| +3% | +$3.52M |
|
707
Denali Therapeutics
DNLI
$3.65B
| $119M | 0.02% |
1,517,021
+264,189
| +21% | +$16.3M |
|
708
Builders FirstSource
BLDR
$7.15B
| $119M | 0.02% |
2,784,244
-672,620
| -19% | -$31.2M |
|
709
Western Alliance Bancorporation
WAL
$8.79B
| $119M | 0.02% |
1,276,344
+17,497
| +1% | +$1.73M |
|
|
ATH
710
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $117M | 0.02% |
1,741,923
+240,304
| +16% | +$14.5M |
|
711
Boston Beer
SAM
$1.91B
| $117M | 0.02% |
114,853
+5,007
| +5% | +$5.62M |
|
712
Neurocrine Biosciences
NBIX
$16.8B
| $117M | 0.02% |
1,203,134
+23,626
| +2% | +$2.26M |
|
|
SYNH
713
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $117M | 0.02% |
1,304,938
+247,121
| +23% | +$20.9M |
|
714
Canadian Imperial Bank of Commerce
CM
$108B
| $117M | 0.02% |
2,054,236
+226,262
| +12% | +$12.4M |
|
715
First Industrial Realty Trust
FR
$8.73B
| $117M | 0.02% |
2,231,862
+37,469
| +2% | +$1.88M |
|
|
BERY
716
DELISTED
Berry Global Group, Inc.
BERY
| $116M | 0.02% |
1,942,229
+157,229
| +9% | +$9.46M |
|
717
Natera
NTRA
$38.3B
| $116M | 0.02% |
1,024,225
-300,793
| -23% | -$30.8M |
|
|
AMED
718
DELISTED
Amedisys
AMED
| $115M | 0.02% |
471,252
+29,577
| +7% | +$7.76M |
|
719
Donaldson
DCI
$10.9B
| $115M | 0.02% |
1,815,224
+210,228
| +13% | +$13M |
|
720
Vistra
VST
$50B
| $115M | 0.02% |
6,205,533
-408,286
| -6% | -$7.05M |
|
721
HealthEquity
HQY
$8.41B
| $115M | 0.02% |
1,425,310
+62,468
| +5% | +$4.76M |
|
722
Texas Roadhouse
TXRH
$13.5B
| $114M | 0.02% |
1,189,593
+71,584
| +6% | +$7.04M |
|
723
Jefferies Financial Group
JEF
$12.6B
| $114M | 0.02% |
3,499,335
+223,439
| +7% | +$6.82M |
|
724
Bright Horizons
BFAM
$3.92B
| $114M | 0.02% |
777,319
+15,393
| +2% | +$2.3M |
|
|
HRC
725
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $114M | 0.02% |
1,006,578
+27,454
| +3% | +$3.07M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.